EA033459B1 - Конденсированные спироциклические гетероароматические соединения для лечения бактериальных инфекций - Google Patents
Конденсированные спироциклические гетероароматические соединения для лечения бактериальных инфекцийInfo
- Publication number
- EA033459B1 EA033459B1 EA201692250A EA201692250A EA033459B1 EA 033459 B1 EA033459 B1 EA 033459B1 EA 201692250 A EA201692250 A EA 201692250A EA 201692250 A EA201692250 A EA 201692250A EA 033459 B1 EA033459 B1 EA 033459B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- spp
- bacterial infections
- fused
- treatment
- heteroaromatic compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/527—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim spiro-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Предложено применение (2R,4S,4aS)-11-фтор-2,4-диметил-8-[(4S)-4-метил-2-оксо-1,3-оксазолидин-3-ил]-1,2,4,4а-тетрагидро-2'H,6H-спиро[1,4-оксазино[4,3-а][1,2]оксазоло[4,5-g]хинолин-5,5'-пиримидин]-2',4',6'(1'H,3'H)триона или его фармацевтически приемлемой соли для лечения различных бактериальных инфекций, которые вызваны одним или более видами бактерий, выбранными из Brucella spp., Francisella spp., Yersinia spp., Mycoplasma spp., Ureaplasma spp., Chlamydia trachomatis или Chlamydia pneumoniae.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462004246P | 2014-05-29 | 2014-05-29 | |
PCT/IB2015/001585 WO2015181637A1 (en) | 2014-05-29 | 2015-05-27 | Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201692250A1 EA201692250A1 (ru) | 2017-06-30 |
EA033459B1 true EA033459B1 (ru) | 2019-10-31 |
Family
ID=54329851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201692250A EA033459B1 (ru) | 2014-05-29 | 2015-05-27 | Конденсированные спироциклические гетероароматические соединения для лечения бактериальных инфекций |
Country Status (14)
Country | Link |
---|---|
US (1) | US10238661B2 (ru) |
EP (1) | EP3148546A1 (ru) |
JP (1) | JP6502387B6 (ru) |
KR (1) | KR20170007818A (ru) |
CN (1) | CN106659725A (ru) |
AU (1) | AU2015265620B2 (ru) |
CA (1) | CA2948438A1 (ru) |
EA (1) | EA033459B1 (ru) |
IL (1) | IL248838B (ru) |
MX (1) | MX365261B (ru) |
PH (1) | PH12016502271B1 (ru) |
SG (2) | SG10201906842WA (ru) |
TW (1) | TWI657818B (ru) |
WO (1) | WO2015181637A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109111465B (zh) | 2017-06-22 | 2021-01-12 | 中国科学院上海药物研究所 | 噻唑烷酮螺嘧啶三酮类化合物及制备方法和用途 |
US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010043893A1 (en) * | 2008-10-14 | 2010-04-22 | Astrazeneca Ab | Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
WO2014114929A1 (en) * | 2013-01-23 | 2014-07-31 | Astrazeneca Ab | Compounds and methods for treating bacterial infections |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7208490B2 (en) | 2002-10-07 | 2007-04-24 | Pharmacia & Upjohn Company Llc | Tricyclic tetrahydroquinoline antibacterial agents |
JP2007502307A (ja) | 2003-08-15 | 2007-02-08 | アストラゼネカ アクチボラグ | グルタミン酸ラセマーゼ(muri)の阻害剤としての縮合複素環 |
CA2606847A1 (en) | 2005-05-09 | 2006-11-16 | Warner-Lambert Company Llc | Antibacterial agents |
DOP2006000268A (es) | 2005-12-22 | 2007-07-31 | Pfizer Prod Inc | Agentes antibacterianos |
CL2007003332A1 (es) | 2006-11-24 | 2008-06-20 | Actelion Pharmaceuticals Ltd | Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas. |
RU2010103101A (ru) | 2007-07-02 | 2011-08-10 | Астразенека Аб (Se) | Химические соединения |
US9040528B2 (en) | 2008-10-14 | 2015-05-26 | Astrazeneca Ab | Chemical compounds 542 |
AR084070A1 (es) | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
US8952149B2 (en) | 2012-09-26 | 2015-02-10 | Zoetis Llc | Tricyclic tetrahydroquinoline antibacterial agents |
-
2015
- 2015-05-27 EP EP15781402.1A patent/EP3148546A1/en not_active Withdrawn
- 2015-05-27 WO PCT/IB2015/001585 patent/WO2015181637A1/en active Application Filing
- 2015-05-27 MX MX2016015632A patent/MX365261B/es active IP Right Grant
- 2015-05-27 JP JP2016568934A patent/JP6502387B6/ja not_active Expired - Fee Related
- 2015-05-27 AU AU2015265620A patent/AU2015265620B2/en not_active Ceased
- 2015-05-27 SG SG10201906842WA patent/SG10201906842WA/en unknown
- 2015-05-27 CA CA2948438A patent/CA2948438A1/en not_active Abandoned
- 2015-05-27 EA EA201692250A patent/EA033459B1/ru not_active IP Right Cessation
- 2015-05-27 CN CN201580027395.7A patent/CN106659725A/zh active Pending
- 2015-05-27 KR KR1020167035906A patent/KR20170007818A/ko not_active Application Discontinuation
- 2015-05-27 SG SG11201609404SA patent/SG11201609404SA/en unknown
- 2015-05-27 US US15/314,660 patent/US10238661B2/en not_active Expired - Fee Related
- 2015-05-28 TW TW104117219A patent/TWI657818B/zh not_active IP Right Cessation
-
2016
- 2016-11-08 IL IL248838A patent/IL248838B/en not_active IP Right Cessation
- 2016-11-15 PH PH12016502271A patent/PH12016502271B1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010043893A1 (en) * | 2008-10-14 | 2010-04-22 | Astrazeneca Ab | Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
WO2014114929A1 (en) * | 2013-01-23 | 2014-07-31 | Astrazeneca Ab | Compounds and methods for treating bacterial infections |
Non-Patent Citations (4)
Title |
---|
Huband M.D. et al.: "In Vitro Antibacterial Activity of AZD0914 and Comparators againt Mycoplasma, Ureaplasma and Chlamydia", INTERNET 6 September 2014 (2014-09-06), XP002749518, Retrieved from the Internet:URL:http://www.icaaconline.com/php/icaac2014abstracts/data/papers/2014/F-265.htm [retrieved on 2015-10-30] abstract * |
Huband M.D. et al.: "In Vitro Antibacterial Activity of AZD0914: A New Spiropyrimidinetrione Bacterial DNA Gyrase Inhibitor against Potential Agents of Bioterrorism", INTERNET, 6 September 2014 (2014-09-06), XP002749519, Retrieved from the Internet:URL:http://www.icaaconline.com/php/icaac2014abstracts/data/papers/2014/F-264.htm [retrieved on 2015-10-30]abstract * |
STEPHAN A. KOHLHOFF, MICHAEL D. HUBAND AND MARGARET R. HAMMERSCHLAG: "In Vitro Activity of AZD0914, a Novel DNA Gyrase Inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 58, no. 12, 1 December 2014 (2014-12-01), US, pages 7595 - 7596, XP002749516, ISSN: 0066-4804, DOI: 10.1128/AAC.03920-14 * |
Waites K.B. et al.: "In Vitro Antibacterial Activity of AZD0914 Against Human Mycoplasmas and Ureaplasmas", INTERNET 25 March 2015 (2015-03-25), XP002749517, Retrieved from the Internet:URL:http://aac.asm.org/content/early/2015/03/24/AAC.04945-14.ful1.pdf [retrieved on 2015-10-30] the whole document * |
Also Published As
Publication number | Publication date |
---|---|
SG11201609404SA (en) | 2016-12-29 |
AU2015265620A1 (en) | 2016-11-24 |
PH12016502271A1 (en) | 2017-02-06 |
MX2016015632A (es) | 2017-04-25 |
IL248838B (en) | 2020-05-31 |
WO2015181637A1 (en) | 2015-12-03 |
MX365261B (es) | 2019-05-27 |
JP6502387B6 (ja) | 2019-05-29 |
EA201692250A1 (ru) | 2017-06-30 |
CN106659725A (zh) | 2017-05-10 |
IL248838A0 (en) | 2017-01-31 |
PH12016502271B1 (en) | 2017-02-06 |
US10238661B2 (en) | 2019-03-26 |
JP6502387B2 (ja) | 2019-04-17 |
KR20170007818A (ko) | 2017-01-20 |
EP3148546A1 (en) | 2017-04-05 |
JP2017516777A (ja) | 2017-06-22 |
TW201607537A (zh) | 2016-03-01 |
US20180169104A1 (en) | 2018-06-21 |
AU2015265620B2 (en) | 2020-04-09 |
CA2948438A1 (en) | 2015-12-03 |
SG10201906842WA (en) | 2019-08-27 |
TWI657818B (zh) | 2019-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3523311A4 (en) | SUBSTITUTED 1H-IMIDAZO [4,5-B] PYRIDINE-2 (3H) -ONE AND THE USE THEREOF AS GLUN2B RECEPTOR MODULATORS | |
EP4338739A3 (en) | Diaryl macrocycles as modulators of protein kinases | |
HK1203483A1 (en) | Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections | |
MX2016015218A (es) | Antibioticos macrociclicos de amplio espectro. | |
CL2015002591A1 (es) | Entidades químicas. | |
GEP20227406B (en) | Chromane monobactam compounds for the treatment of bacterial infections | |
CL2012002124A1 (es) | Polvo de rifaximina que comprende un tamaño de partícula entre 40 y 120 micrómetros; composiciones de liberacion controlada que contienen dicha rifaximina y su proceso de preparación, util para el tratamiento de infección intestinales bacterianas.. | |
WO2016100578A3 (en) | Antimicrobial polymyxins for treatment of bacterial infections | |
SG10201810660QA (en) | Alkyl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain | |
MX2017014438A (es) | Cristales de compuesto azabiciclico. | |
WO2015110969A3 (en) | Nitrogen containing compounds and their use as antibacterial agents | |
PH12016501988A1 (en) | Antibacterial compounds | |
MX2016016363A (es) | Compuestos que comprenden un sistema de 1,1',2,5'-tetrahidroespiro [indol-3,2'-pirrol]-2,5'-diona como inhibidores de la interaccion de proteina-proteina p53-mdm2. | |
MX2017001218A (es) | [1,2,4]triazolo[4,3-b]piridazinas para uso en el tratamiento de enfermedades proliferativas. | |
EA033459B1 (ru) | Конденсированные спироциклические гетероароматические соединения для лечения бактериальных инфекций | |
ZA201800722B (en) | Antibacterial agents comprising a pyrazino[2,3-b][1,4]oxazin-3-one or a related ring system | |
CL2016001024A1 (es) | Compuestos derivados de pirido[4,3-b]pirazin-2-carboxamidas; procedimiento de preparacion; composicion farmaceutica y uso para el tratamiento de trastornos neurodegenerativos, esquizofrenia, depresion, entre otras enfermedades. | |
CL2016000482A1 (es) | Compuestos de tipo 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mglur2 | |
DK3218382T3 (da) | 2,3-dihydro-thiazolo[3,2-a]pyridin-5-on derivativer som antibiotika til behandling af klamydiainfektioner | |
HUE054832T2 (hu) | Pirido-imidazo rifamicinszármazékok baktériumellenes szerként | |
PH12015500518A1 (en) | Tricyclic tetrahydroquinoline antibacterial agents | |
NZ714742A (en) | Solid forms of 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, compositions thereof and methods of their use | |
EA201390620A1 (ru) | ОКСАЗОЛО[5,4-b]ПИРИДИН-5-ИЛЬНЫЕ СОЕДИНЕНИЯ | |
MX2015014657A (es) | Nuevos agentes antibacterianos de fenicol. | |
TN2013000231A1 (en) | Oxazolo [5, 4 -b] pyridin- 5 -yl compounds and their use for the treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM RU |